OBJECTIVE: Hyperactivity of the hypothalamus-pituitary-adrenal (HPA) axis is frequently found in hyperinsulinemic subjects, such as patients with diabetes or abdominal obesity. Here, the question has been posed as to whether hyperinsulinemia increases HPA secretory activity. METHODS: We performed paired -euglycemic and stepwise hypoglycemic (76 -66 -56 -46 mg=dl) -clamp experiments in two groups (each of 15 healthy men) at different insulin infusions rates, ie, 1.5 mU=min=kg (low-insulin condition) and 15.0 mU=min=kg (high-insulin condition). RESULTS: During the euglycemic clamp, the high rate insulin infusion increased plasma ACTH levels, whereas plasma ACTH levels remained essentially unchanged during the low-insulin condition (condition by time interaction, P ¼ 0.008). Likewise, serum cortisol levels were higher during the high-vs low-insulin condition (condition by time interaction, P ¼ 0.004). During the hypoglycemic clamp, plasma ACTH levels did not differ between the low-vs high-insulin condition, while serum cortisol levels were higher during the high-vs low-insulin condition at the beginning of the clamp (plasma glucose $ 76 mg=dl; P ¼ 0.032). CONCLUSION: Data indicate that hyperinsulinemia acutely increases HPA secretory activity in healthy men. This finding appears to be relevant to the pathogenesis of many clinical abnormalities associated which diabetes and abdominal adiposity, often referred to as the metabolic syndrome.
Introduction
Hyperinsulinemic subjects, such as patients with diabetes or abdominal obesity, often show a hyperactivity of the hypothalamus-pituitary-adrenal (HPA) axis. In patients with diabetes this hyperactivity of the HPA axis is indicated by elevated basal plasma cortisol concentrations, 1,2 increased urinary free cortisol, 3 enhanced cortisol response to CRH administration, 2, 4 and a high prevalence of nonsuppression to the dexamethasone suppression test. 5, 6 Likewise, in patients with abdominal adiposity the hyperactivity of the HPA axis is indicated by increased urinary free cortisol, 7 higher response to different stimulation tests 7, 8 and a decrease in the inhibition of cortisol secretion by dexamethasone. 9 The causes of HPA hyperactivity in those hyperinsulinemic subjects remain obscure. Here, we hypothesized that hyperinsulinemia could have a stimulatory influence on HPA secretory activity.
Methods
Thirty young healthy men participated in the experiments (age: mean AE s.e.m. 26 AE 1 y; body mass index (BMI): 22.5 AE 0.6 kg=m 2 ) after providing written informed consent. The study was approved by the local ethics committee. Each subject subsequently underwent a hyperinsulinemic-hypoglycemic and a hyperinsulinemic-euglycemic clamp experiment, with the order of conditions balanced across subjects. Experiments were performed in a single blind fashion. Both clamp sessions for an individual were separated by an interval of at least 4 weeks. All 30 subjects were randomly assigned to two different groups of 15 subjects each. In one group insulin was infused at a rate of 1.5 mU=min=kg during both clamp sessions (low-insulin condition), while in the other group insulin was infused at a rate of 15.0 mU=min=kg during both clamp sessions (high-insulin condition).
After a 1 h baseline period, insulin (H-insulin, Hoechst, Frankfurt, Germany) was infused at a continuous rate of either 1.5 mU=min=kg or 15.0 mU=min=kg for the next 6 h, respectively. Arterialized blood was drawn at 5 min intervals to measure plasma glucose concentration (Beckman Glucose Analyser, Munich, Germany). A 20% glucose solution was simultaneously infused at a variable rate to control plasma glucose levels. Plasma glucose levels were kept normal during the euglycemic clamps and reduced in a stepwise manner during the hypoglycemic clamps to achieve four respective plateaus of approximately 76, 66, 56 and 46 mg=dl. Blood samples were collected every 30 min. Serum insulin and cortisol as well as plasma ACTH concentrations were measured as previously described. 10 All values are presented as mean AE s.e.m. Statistical analysis was based on analysis of covariance for repeated measures (ANCOVA). All values were adjusted for baseline differences by taking baseline values (0 min) as covariate. A P-value < 0.05 was considered significant.
Results
During both the euglycemic and the hypoglycemic clamp, plasma glucose levels did not differ between the low-and high-insulin condition, whereas serum insulin levels were 40-fold higher during the high-vs low-insulin condition (euglycemic clamp: 91 AE 6 vs 4005 AE 266 mU=ml; hypoglycaemic clamp: 104 AE 5 vs 3937 AE 265 mU=ml).
The data of the plasma ACTH and serum cortisol measurements are summarized in Table 1 . During the euglycemic clamp, plasma ACTH levels increased in the high-insulin condition, while they remain essentially unchanged in the low-insulin condition (condition by time interaction, P ¼ 0.008). Similarly, during the euglycemic clamp, serum cortisol levels slightly increased in the high-insulin condition, while they decreased in the low-insulin condition (condition by time interaction, P ¼ 0.004).
During the hypoglycemic clamp, plasma ACTH levels increased in a similar pattern in both conditions. Likewise, serum cortisol levels increased to similar peak values in both conditions. However, during the first hypoglycemic plateau, ie when plasma glucose was about 76 mg=dl, serum cortisol levels were distinctly higher in the high-vs low-insulin condition (12.7 AE 1.1 vs 8.7 AE 1.0 mg=dl; P ¼ 0.032).
Discussion
The present data indicate an acute stimulating effect of insulin on HPA secretory activity during euglycemia in healthy men. Since both plasma ACTH and serum cortisol levels were found to be higher during the high-vs lowinsulin condition, it seems likely that the effects of insulin pertained to the pituitary or central nervous stages of the axis.
The present finding of an acute stimulating effect of insulin on HPA secretory activity during euglycemia agrees with previous observations of increasing plasma cortisol levels during hyperinsulinemic-euglycemic clamp experiments in animals 11 and in humans. 12 Although during hypoglycemia different insulin infusion rates had no effect on the ACTH and cortisol response in the present study, previous studies 13 -15 provided evidence for a dose-dependent amplifying effect of insulin on HPA response to hypoglycemia. Moreover, Davis et al 16 demonstrated that a selective increase in the level of insulin in the blood perfusing the brain amplified the cortisol response to hypoglycemia in dogs, indicating that insulin directly acts on the brain. Taken together, the previous and present results provide strong evidence that hyperinsulinemia increases basal as well as hypoglycemia-stimulated HPA secretory activity.
Hypercortisolism induced by chronic stressors has been hypothesized by several researchers 17, 18 to cause all of the effects of the metabolic syndrome (abdominal adiposity, hypertension, atherosclerosis and coronary artery disease). The present data suggests that hyperinsulinemia as well as stress could also induce hypercortisolism. Therefore, the present finding may hint to a new aspect in the pathogenesis of the metabolic syndrome. 
